Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide synthase 2 pseudogene 3 (NOS2P3) is a non-functional genomic sequence related to the inducible nitric oxide synthase gene (NOS2), located within the Smith-Magenis syndrome chromosome region. Pseudogenes such as NOS2P3 do not encode active enzymes or proteins and are typically transcriptionally silent, though some pseudogenes in other contexts have been implicated in the regulation of related gene expression through RNA interference or dominant-negative forms. For NOS2P3 specifically, there is no evidence of functional protein-coding capacity or direct involvement in human disease or therapeutics. Key Cautions: - Do not confuse NOS2 pseudogenes (such as NOS2P3) with their functional paralog, NOS2 (inducible nitric oxide synthase or iNOS), which does play significant biological and therapeutic roles. - If you are seeking information about functional nitric oxide synthases for therapeutic or pharmacological purposes, NOS2—not NOS2P3—should be investigated. Summary of Inaccuracies/Issues: - NOS2P3 is a pseudogene, not a biologically active molecule or therapeutic target. - It should not be used in place of or conflated with NOS2 or other genuine nitric oxide synthase proteins.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase 2 pseudogene 3 (NOS2P3).